How does COVID-19 affect prostate cancer?

Published Date: 14 Mar 2023

As the COVID-19 pandemic spreads, access to and delivery of health services has been disrupted like never before. How has it affected the treatment of prostate cancer?

Read Full News

Latest News

Next Step for Australian UCCs: Ensuring Quality and Safety

Two recent surveys suggest eight ways in which quality care and safety can be promoted at Medicare urgent care clinics.

S3 Episode 6: Epidemiology of Endometrial Cancer

Drs Ursula A. Matulonis and Immaculata De Vivo discuss the epidemiology of endometrial cancer and how clinicians can use information about risk factors.

Game Changers: Navigating Zongertinib’s Role in HER2+ NSCLC

Dr Mark Kris discusses zongertinib in HER2+ NSCLC, detailing its efficacy, dosing, and key tolerability advantages.

Spotting Seborrheic Keratosis vs Melanoma in Primary Care

In primary care settings, recognizing the difference between seborrheic keratosis and melanoma can guide timely biopsy and reduce missed diagnoses.

Beyond Water and Oxalate: New Era in Kidney Stone Prevention

New approaches to kidney stone prevention are combining traditional diet therapy with insights from genetics, metabolomics, and the microbiome.

Lyme Disease 101: Stages, Testing, and Prevention

Not every Lyme case comes with a bullseye rash, and not every case needs a blood test. The Curbsiders clear up the confusion around Lyme's stages, testing, and coinfections.

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Latest News

Two recent surveys suggest eight ways in which quality care and safety can be promoted at Medicare urgent care clinics.

Drs Ursula A. Matulonis and Immaculata De Vivo discuss the epidemiology of endometrial cancer and how clinicians can use information about risk factors.

Dr Mark Kris discusses zongertinib in HER2+ NSCLC, detailing its efficacy, dosing, and key tolerability advantages.

In primary care settings, recognizing the difference between seborrheic keratosis and melanoma can guide timely biopsy and reduce missed diagnoses.

New approaches to kidney stone prevention are combining traditional diet therapy with insights from genetics, metabolomics, and the microbiome.

Not every Lyme case comes with a bullseye rash, and not every case needs a blood test. The Curbsiders clear up the confusion around Lyme's stages, testing, and coinfections.

News All Time

Anti-Amyloids and Meaningful Change

Preventive neurologists Richard Isaacson and Jennifer Buczyner discuss the role of anti-amyloid drugs in patients with Alzheimer’s or mild cognitive impairment.

Can One Blood Test Detect 50 Cancers Early?

The latest evidence suggests multicancer early detection could expand screening beyond mammography and colonoscopy, yet key questions on outcomes and false positives remain.

A 5-Week-Old Male Presents With Blisters on His Right Leg

Examination revealed pink inflammatory papules and vesicles with areas of brown scale in a linear distribution extending from just above the right medial malleolus to the right inguinal crease.

Fever and Rash Reveal Japanese Spotted Fever in Woman

Recognizing fever, rash, and an eschar after tick exposure can support early diagnosis and timely antibiotic treatment, reducing the risk for severe complications.

Lost in Translation: Cancer Care's Coordination Problem

No shared records. No standard handoff. No common language. Three physicians break down why cancer care coordination keeps failing.

S3 Episode 5: The Future of Endometrial Cancer Pathology

Drs Ursula A. Matulonis and Marisa R. Nucci discuss the future of AI and pathology and how genetics and genomics play a role in the diagnosis of endometrial cancer.

What ASCO 2026 Taught Us About Scaling AI in Cancer Care

The next era of oncology AI won’t be won by the best model, the highest benchmarks, or flashiest press release. It will be won by the most reliable pathway to deployability.

Practice-Changing Data in GI Oncology

From ASCO 2026, Dr Mark Lewis breaks down a 'transformational' shift in GI oncology, from the historic RAS revolution to biomarker-driven advances in colon cancer.

S1 Episode 1: Can Primary Care Catch MASLD Before Cirrhosis?

MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.

S1 Episode 2: Recurrent UTIs in Older Women

Drs Anne Lenore Ackerman and Melissa Kaufman discuss recurrent UTIs in older women and its association with genitourinary syndrome of menopause.

Herpes Simplex Virus Esophagitis in an Immunocompetent Man

Severe esophageal symptoms that do not respond to standard treatment may warrant endoscopic evaluation and targeted diagnostic testing.

Tailoring Prostate Cancer Care in Men With Limited Longevity

Not every man with prostate cancer benefits from aggressive therapy. Drs Timothy Daskivich and John Leppert explore how to avoid overtreatment in men with limited longevity.

Older Man With Lyme Neuroborreliosis After Tick Bite

Facial palsy, encephalitis, and cerebrospinal fluid abnormalities ultimately indicated Lyme neuroborreliosis, despite early doxycycline treatment.

HLTH Europe 2026

Read clinically focused news coverage of key developments from HLTH Europe 2026

Data Updates Shift Treatment Standards in Gyn-Oncology

At ASCO 2026, Dr Susana Campos reviews pivotal gyn-onc updates, from practice-changing long-term IO survival in endometrial cancer to next-generation ADCs.

UC Care Shifts: What’s Changed in the New ACG Guideline?

In this interview, Dr David Rubin discusses the changes in ulcerative colitis care that led to the ACG clinical guideline update.

Recommended News For You

Joe Biden has prostate cancer with bone spread. An oncologist explains what you need to know

Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy

In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.

iPSC-based vaccines: A new hope for preventing and treating colorectal cancer

Study sheds light on challenges for women of color after breast cancer surgery

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

Is Exercise an Effective Treatment for Prostate Cancer?

Recommended Articles For You

Macrocytic Anemia: A Comprehensive Review of Pathophysiology, Diagnosis, and Clinical Management 

Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology 

Bone Marrow Niche Dysregulation in Hematologic Disorders 

Exploring New Solutions for MCV Low: Unlocking the Potential for Improved Health 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Radiotherapy after mastectomy can be avoided, study finds

2.

The Higher the Disability Burden From Disease, the Higher the Suicide Risk

3.

Healthy weight loss could lower your odds for cancer

4.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

5.

High Response Rate in Heavily Treated Multiple Myeloma With Novel Drug Combination

1.

Understanding Fibrosarcoma: What You Need to Know 

2.

Adaptive Cellular Immunotherapy for Advanced Malignancies

3.

What You Need To Know About Secondary Polycythemia: Treatment & Symptoms

4.

CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review

5.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

4.

Breast Cancer Awareness and Early Detection

5.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot